Multiparametric MRI (mp-MRI) of the prostate currently provides stable and reproducible performances.
The usefulness of dynamic contrast-enhanced (DCE) sequences is currently challenged, as they sometimes only confirm what has already been observed on diffusion-weighted imaging (DWI) and require the additional purchase of a contrast agent. Eliminating these sequences may help accelerate the use of MRI in addition to, or in lieu of, prostate biopsies in selected patients. However, many studies show that these sequences can detect lesions invisible on T2-weighted and diffusion-weighted images, better assess cancer extension and aggressiveness, and finally help detecting recurrence after treatment. We present the various applications of dynamic MRI and discuss the possible consequences of its omission from the current protocol.
Written by:
Puech P, Sufana-Iancu A, Renard B, Lemaitre L. Are you the author?
Department of Uroradiology, Lille Hospital, 1, rue Michel-Polonovski, 59037 Lille cedex, France; University of Lille Nord de France, Lille 59800, France; Inserm U703, 59120 Loos, France.
Reference: Diagn Interv Imaging. 2013 Dec;94(12):1299-311.
doi: 10.1016/j.diii.2013.09.010
PubMed Abstract
PMID: 24211261
UroToday.com Prostate Cancer Section
